carbostyril has been researched along with Tuberculosis, Drug-Resistant in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yaqub, F | 1 |
| Monneret, C | 1 |
| Nath, M; Tandon, R | 1 |
| Bai, Y; Hu, Z; Li, J; Lu, J; Luo, R; Tang, Z; Wang, H; Wu, J; Xian, Q; Yue, J; Zhang, X | 1 |
| Bedi, RS | 1 |
| Dashieva, DG; Elistratova, NA; Mikhaĭlova, LP; Mozhokina, GN; Sokolova, GB | 1 |
| Cannas, S; Carta, A; Molicotti, P; Paglietti, B; Paglietti, G; Palomba, M; Zanetti, S | 1 |
| Alpert, P; Blum, S; el-Sadr, W; Gagliardi, A; Mannheimer, S; Medard, F; Salomon, N; Sepkowitz, K; Telzak, EE; Turett, G | 1 |
| Carlos, L; da Silva, C; Müller, L | 1 |
| Klinberg, NM; Mar'iandyshev, AO; Moroz, MI; Shonbina, AI | 1 |
| Padeĭskaia, EN | 1 |
| Martynova, LP; Mishin, VIu; Vasil'eva, IA | 1 |
| Elistratova, NA; Kunichan, AD; Mozhokina, GN; Perel'man, MI; Sokolova, GB | 1 |
3 review(s) available for carbostyril and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
[Two news drugs (ivacaftor & bedaquiline), one biomarker (florbetapir) and a re-positioned drug (propranolol) on the market].
Topics: Adrenergic beta-Antagonists; Adult; Alzheimer Disease; Aminophenols; Aniline Compounds; Antitubercular Agents; Cystic Fibrosis; Diarylquinolines; Drug Resistance, Bacterial; Ethylene Glycols; Hemangioma; Humans; Infant; Propranolol; Quinolones; Radionuclide Imaging; Radiopharmaceuticals; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2014 |
Tackling Drug-Resistant Tuberculosis: Current Trends and Approaches.
Topics: Antitubercular Agents; Benzothiazoles; Cell Wall; Clinical Trials as Topic; Ethylenediamines; Mycobacterium tuberculosis; Nitroimidazoles; Quinolones; Rifamycins; Tuberculosis, Multidrug-Resistant | 2017 |
[Difluoroquinolone lomefloxacin (Maxaquin): its role among fluoroquinolones, possibilities and prospectives].
Topics: Anti-Infective Agents; Antitubercular Agents; Fluoroquinolones; Humans; Legionellosis; Meningitis, Bacterial; Quinolones; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
2 trial(s) available for carbostyril and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
Multidrug-resistant tuberculosis.
Topics: Amikacin; Antitubercular Agents; Brazil; Drug Therapy, Combination; HIV Seronegativity; Humans; Quinolones; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 1996 |
[Maxaquin in the combined treatment of tuberculosis].
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Culture Techniques; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fluoroquinolones; Humans; Lung; Mice; Mycobacterium tuberculosis; Quinolones; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2000 |
8 other study(ies) available for carbostyril and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
2013 American Thoracic Society International Conference.
Topics: alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Analgesics, Non-Narcotic; Asthma; Benzamides; Clofazimine; Congresses as Topic; Cyclobutanes; Drug Combinations; Glycopyrrolate; Hospital Mortality; Humans; Indans; Intensive Care Units; Lung; Pulmonary Disease, Chronic Obstructive; Quinolones; Societies, Medical; Thoracic Diseases; Treatment Outcome; Tuberculosis, Multidrug-Resistant; United States | 2013 |
In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Cell Line, Tumor; Colony Count, Microbial; Drug Evaluation, Preclinical; Female; Haplorhini; Humans; Hydrazines; Isoniazid; Lung; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinolones; Spleen; Survival Analysis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2010 |
Saving quinolones for tuberculosis.
Topics: Anti-Infective Agents; Antitubercular Agents; Humans; Quinolones; Tuberculosis, Multidrug-Resistant | 2003 |
[Comparative efficiency of treatment with moxyfloxacin and lomefloxacin for generalized murine tuberculosis caused by drug-resistant Mycobacterium strains].
Topics: Animals; Antitubercular Agents; Aza Compounds; Disease Models, Animal; Drug Therapy, Combination; Fluoroquinolones; Liver; Lung; Mice; Moxifloxacin; Mycobacterium tuberculosis; Quinolines; Quinolones; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2005 |
[1,2,3]Triazolo[4,5-h]quinolones. A new class of potent antitubercular agents against multidrug resistant Mycobacterium tuberculosis strains.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Chemistry, Pharmaceutical; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Models, Chemical; Mycobacterium tuberculosis; Quinolones; Triazoles; Tuberculosis, Multidrug-Resistant | 2007 |
Multidrug-resistant tuberculosis in patients without HIV infection.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Seronegativity; Humans; Male; Middle Aged; New York City; Pneumonectomy; Quinolones; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 1995 |
[Use of maxaquin in the treatment of progressive pulmonary tuberculosis occurring with standard chemotherapy regimens].
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Disease Progression; Drug Resistance, Microbial; Fluoroquinolones; Follow-Up Studies; Humans; Middle Aged; Mycobacterium tuberculosis; Quinolones; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1997 |
[Efficiency of lomefloxacine in combined treatment of patients with multiresistant pulmonary tuberculosis complicated with nonspecific bronchopulmonary infection].
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Fluoroquinolones; Humans; Isoniazid; Middle Aged; Quinolones; Respiratory Tract Infections; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1999 |